These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 12658736)
1. Expression of Ku86 confers favorable outcome of tonsillar carcinoma treated with radiotherapy. Friesland S; Kanter-Lewensohn L; Tell R; Munck-Wikland E; Lewensohn R; Nilsson A Head Neck; 2003 Apr; 25(4):313-21. PubMed ID: 12658736 [TBL] [Abstract][Full Text] [Related]
2. Expressions of Ku70 and DNA-PKcs as prognostic indicators of local control in nasopharyngeal carcinoma. Lee SW; Cho KJ; Park JH; Kim SY; Nam SY; Lee BJ; Kim SB; Choi SH; Kim JH; Ahn SD; Shin SS; Choi EK; Yu E Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1451-7. PubMed ID: 16029807 [TBL] [Abstract][Full Text] [Related]
3. [Potentials of DNA-PKcs, Ku80, and ATM in enhancing radiosensitivity of cervical carcinoma cells]. Zhuang L; Yu SY; Huang XY; Cao Y; Xiong HH Ai Zheng; 2007 Jul; 26(7):724-9. PubMed ID: 17626748 [TBL] [Abstract][Full Text] [Related]
4. Ku70 predicts response and primary tumor recurrence after therapy in locally advanced head and neck cancer. Pavón MA; Parreño M; León X; Sancho FJ; Céspedes MV; Casanova I; Lopez-Pousa A; Mangues MA; Quer M; Barnadas A; Mangues R Int J Cancer; 2008 Sep; 123(5):1068-79. PubMed ID: 18546291 [TBL] [Abstract][Full Text] [Related]
5. Ku86 variant expression and function in multiple myeloma cells is associated with increased sensitivity to DNA damage. Tai YT; Teoh G; Lin B; Davies FE; Chauhan D; Treon SP; Raje N; Hideshima T; Shima Y; Podar K; Anderson KC J Immunol; 2000 Dec; 165(11):6347-55. PubMed ID: 11086072 [TBL] [Abstract][Full Text] [Related]
6. Human papilloma virus (HPV) and p53 immunostaining in advanced tonsillar carcinoma--relation to radiotherapy response and survival. Friesland S; Mellin H; Munck-Wikland E; Nilsson A; Lindholm J; Dalianis T; Lewensohn R Anticancer Res; 2001; 21(1B):529-34. PubMed ID: 11299799 [TBL] [Abstract][Full Text] [Related]
7. c-erbB-2 oncoprotein expression related to chemoradioresistance in esophageal squamous cell carcinoma. Akamatsu M; Matsumoto T; Oka K; Yamasaki S; Sonoue H; Kajiyama Y; Tsurumaru M; Sasai K Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1323-7. PubMed ID: 14630269 [TBL] [Abstract][Full Text] [Related]
8. An antisense oligonucleotide targeted to human Ku86 messenger RNA sensitizes M059K malignant glioma cells to ionizing radiation, bleomycin, and etoposide but not DNA cross-linking agents. Belenkov AI; Paiement JP; Panasci LC; Monia BP; Chow TY Cancer Res; 2002 Oct; 62(20):5888-96. PubMed ID: 12384553 [TBL] [Abstract][Full Text] [Related]
9. Radioresistant cervical cancer shows upregulation of the NHEJ proteins DNA-PKcs, Ku70 and Ku86. Beskow C; Skikuniene J; Holgersson A; Nilsson B; Lewensohn R; Kanter L; Viktorsson K Br J Cancer; 2009 Sep; 101(5):816-21. PubMed ID: 19672258 [TBL] [Abstract][Full Text] [Related]
10. Expression of DNA-PKcs and Ku86, but not Ku70, differs between lymphoid malignancies. Holgersson A; Erdal H; Nilsson A; Lewensohn R; Kanter L Exp Mol Pathol; 2004 Aug; 77(1):1-6. PubMed ID: 15215044 [TBL] [Abstract][Full Text] [Related]
11. Decreased expression of DNA-dependent protein kinase, a DNA repair protein, during human colon carcinogenesis. Rigas B; Borgo S; Elhosseiny A; Balatsos V; Manika Z; Shinya H; Kurihara N; Go M; Lipkin M Cancer Res; 2001 Dec; 61(23):8381-4. PubMed ID: 11731412 [TBL] [Abstract][Full Text] [Related]
12. Impact of telomerase ablation on organismal viability, aging, and tumorigenesis in mice lacking the DNA repair proteins PARP-1, Ku86, or DNA-PKcs. Espejel S; Klatt P; Ménissier-de Murcia J; Martín-Caballero J; Flores JM; Taccioli G; de Murcia G; Blasco MA J Cell Biol; 2004 Nov; 167(4):627-38. PubMed ID: 15545322 [TBL] [Abstract][Full Text] [Related]
13. Transfer of Ku86 RNA antisense decreases the radioresistance of human fibroblasts. Marangoni E; Le Romancer M; Foray N; Muller C; Douc-Rasy S; Vaganay S; Abdulkarim B; Barrois M; Calsou P; Bernier J; Salles B; Bourhis J Cancer Gene Ther; 2000 Feb; 7(2):339-46. PubMed ID: 10770645 [TBL] [Abstract][Full Text] [Related]
14. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma. Oda Y; Sakamoto A; Satio T; Kawauchi S; Iwamoto Y; Tsuneyoshi M Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040 [TBL] [Abstract][Full Text] [Related]
15. The immunohistochemical expression of DNA-PKCS and Ku (p70/p80) in head and neck cancers: relationships with radiosensitivity. Björk-Eriksson T; West C; Nilsson A; Magnusson B; Svensson M; Karlsson E; Slevin N; Lewensohn R; Mercke C Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):1005-10. PubMed ID: 10571209 [TBL] [Abstract][Full Text] [Related]
16. The expression pattern of Ku correlates with tumor radiosensitivity and disease free survival in patients with rectal carcinoma. Komuro Y; Watanabe T; Hosoi Y; Matsumoto Y; Nakagawa K; Tsuno N; Kazama S; Kitayama J; Suzuki N; Nagawa H Cancer; 2002 Sep; 95(6):1199-205. PubMed ID: 12216085 [TBL] [Abstract][Full Text] [Related]
17. Clinical studies of immunohistochemical staining of DNA-dependent protein kinase in oropharyngeal and hypopharyngeal carcinomas. Sakata K; Matsumoto Y; Satoh M; Oouchi A; Nagakura H; Koito K; Hosoi Y; Hareyama M; Suzuki N Radiat Med; 2001; 19(2):93-7. PubMed ID: 11383649 [TBL] [Abstract][Full Text] [Related]
18. DNA-PKcs and Ku70 are predictive markers for poor prognosis of patients with gall bladder malignancies. Ren F; Yang ZL; Tan X; Liu D; Zou Q; Yuan Y; Li J; Liang L; Zeng G; Chen S Appl Immunohistochem Mol Morphol; 2014; 22(10):741-7. PubMed ID: 25046228 [TBL] [Abstract][Full Text] [Related]
19. Influence of XRCC4 expression in esophageal cancer cells on the response to radiotherapy. Hori M; Someya M; Matsumoto Y; Nakata K; Kitagawa M; Hasegawa T; Tsuchiya T; Fukushima Y; Gocho T; Sato Y; Ohnuma H; Kato J; Sugita S; Hasegawa T; Sakata KI Med Mol Morphol; 2017 Mar; 50(1):25-33. PubMed ID: 27338590 [TBL] [Abstract][Full Text] [Related]
20. DNA-PKcs-OBA/Ku associate in the absence of DNA, as revealed by two-dimensional capillary gel electromobility shift assay. Ruiz MT; Nichols A; Price GB; Zannis-Hadjopoulos M Electrophoresis; 2002 Aug; 23(15):2485-9. PubMed ID: 12210207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]